Menu
GeneBe

17-31349086-CTTGTTTGTTTGTTTGT-CTTGTTTGTTTGT

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001042492.3(NF1):c.7190-11_7190-8del variant causes a intron change. The variant allele was found at a frequency of 0.0057 in 1,541,198 control chromosomes in the GnomAD database, including 318 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 165 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 153 hom. )

Consequence

NF1
NM_001042492.3 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.75
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 17-31349086-CTTGT-C is Benign according to our data. Variant chr17-31349086-CTTGT-C is described in ClinVar as [Benign]. Clinvar id is 226852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31349086-CTTGT-C is described in Lovd as [Benign]. Variant chr17-31349086-CTTGT-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0836 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NF1NM_001042492.3 linkuse as main transcriptc.7190-11_7190-8del intron_variant ENST00000358273.9
NF1NM_000267.3 linkuse as main transcriptc.7127-11_7127-8del intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NF1ENST00000358273.9 linkuse as main transcriptc.7190-11_7190-8del intron_variant 1 NM_001042492.3 P1P21359-1

Frequencies

GnomAD3 genomes
AF:
0.0254
AC:
3856
AN:
151948
Hom.:
164
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0860
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0113
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.000473
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000985
Gnomad OTH
AF:
0.0197
GnomAD3 exomes
AF:
0.00818
AC:
1265
AN:
154686
Hom.:
44
AF XY:
0.00635
AC XY:
519
AN XY:
81712
show subpopulations
Gnomad AFR exome
AF:
0.0942
Gnomad AMR exome
AF:
0.00742
Gnomad ASJ exome
AF:
0.000360
Gnomad EAS exome
AF:
0.00141
Gnomad SAS exome
AF:
0.00170
Gnomad FIN exome
AF:
0.00292
Gnomad NFE exome
AF:
0.00175
Gnomad OTH exome
AF:
0.00481
GnomAD4 exome
AF:
0.00355
AC:
4927
AN:
1389136
Hom.:
153
AF XY:
0.00310
AC XY:
2128
AN XY:
686016
show subpopulations
Gnomad4 AFR exome
AF:
0.0935
Gnomad4 AMR exome
AF:
0.00856
Gnomad4 ASJ exome
AF:
0.000481
Gnomad4 EAS exome
AF:
0.000730
Gnomad4 SAS exome
AF:
0.00112
Gnomad4 FIN exome
AF:
0.00138
Gnomad4 NFE exome
AF:
0.000967
Gnomad4 OTH exome
AF:
0.00741
GnomAD4 genome
AF:
0.0254
AC:
3860
AN:
152062
Hom.:
165
Cov.:
32
AF XY:
0.0238
AC XY:
1766
AN XY:
74336
show subpopulations
Gnomad4 AFR
AF:
0.0859
Gnomad4 AMR
AF:
0.0113
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.000774
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.000473
Gnomad4 NFE
AF:
0.000985
Gnomad4 OTH
AF:
0.0194
Bravo
AF:
0.0301

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 02, 2015c.7190-11_7190-8delGTTT (HGVS nomenclature: c.7190-31_7190-28[5]) in intron 48 o f NF1: This variant is not expected to have clinical significance because it has been identified in 10.6% (312/2980) of African chromosomes by the Exome Aggrega tion Consortium (ExAC, http://exac.broadinstitute.org; rs149197458). This varian t is not predicted to impact splicing. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 26, 2018- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 16, 2017Variant summary: The NF1 c.7127-11_7127-8delGTTT variant involves the deletion of four intronic nucleotides in a six (GTTT) repeat region. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant, listed as 17:29676104 CTTGT / Cin the ExAC control database, was found in 444/23188 control chromosomes (19 homozygotes), predominantly observed in the African subpopulation at a frequency of 0.104698 (312/2980). This frequency is about 502 times the estimated maximal expected allele frequency of a pathogenic NF1 variant (0.0002084), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, the variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingGeneDxAug 19, 2019- -
Hereditary cancer-predisposing syndrome Benign:1
Benign, criteria provided, single submittercurationSema4, Sema4Jun 12, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149197458; hg19: chr17-29676104; API